September 25th 2011
T-DM1 extended progression-free survival by 40% in HER2+ metastatic breast cancer and was less toxic, compared with standard therapy.
September 24th 2011
Investigational drug that emits alpha radiation shows significant improvement in overall survival.
September 23rd 2011
Two studies enhance understanding of risk factors for prostate cancer.
March 4th 2011
Being obese at the time operable breast cancer is diagnosed is associated with inferior outcomes in women with estrogen receptor (ER) or progesterone receptor (PR)positive, HER2-negative breast cancer.